Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study-Reference-Cited by-同舟云学术

Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study

Published:2015-11-11 Issue:11 Volume:10 Page:e0142217
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Moulis Guillaume,Palmaro Aurore,Sailler Laurent,Lapeyre-Mestre Maryse

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group;F Rodeghiero;Blood,2009

2. Diagnosis and classification of immune-mediated thrombocytopenia;E Lo;Autoimmun Rev,2014

3. International consensus report on the investigation and management of primary immune thrombocytopenia;D Provan;Blood,2010

4. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia;C Neunert;Blood,2011

5. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count;M Khellaf;Haematologica,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Immune Thrombocytopenia Treatment Landscape: A Focus on Patient Perspectives and Unmet Clinical Needs;EMJ Hematology;2024-09-11

2. Longitudinal evaluation of adverse events due to steroid use in primary immune thrombocytopenia: A population‐based study;British Journal of Haematology;2024-03-04

3. How I diagnose and treat thrombocytopenia in geriatric patients;Blood;2024-01-18

4. Not So BenignImmune Thrombocytopenia: New and Emerging Therapies for a Challenging “Benign” Hematologic Disease;The Hematologist;2024

5. Older Adults and Immune Thrombocytopenia: Considerations for the Clinician;Clinical Interventions in Aging;2023-01